Every 30 s, a patient dies from a condition that could be treated with organ replacement [1] . Organ transplantation has potential to be an efficient solution but is restricted due limited donor availability. Furthermore, organ transplantation requires complex surgical interventions and can lead to complications such as organ dysfunction or rejection. Successful translation of tissue engineering and regenerative medicine research is key to alleviating the challenges in organ transplantation, but can also be applied to disease modeling and drug discovery (Figure 1 ). More specifically, improved understanding of the biological architecture and natural repair processes in adult tissues could aid the challenging fabrication of de novo organs, for these applications. For cells to self-assemble into tissues, they need an environment in which cells can remain viable and are able to adhere and migrate. The most important factors to consider are growth factors, nutrients, adhesion molecules, cells, materials and the technologies applied to enhance the fabrication process [2] . This review focuses on developments in bioprinting for musculoskeletal tissue engineering, and provides discussion on the various approaches for bone, cartilage and connective tissue fabrication, along with current challenges and future perspectives.
Bioprinting & its role in musculoskeletal tissue fabrication
The musculoskeletal system (MSK) provides structural support for the body and comprises of vital tissue components such as bone, cartilage, muscles, tendons and ligaments. When these tissues are damaged through injury, their repair remains challenging due to their limited regenerative potential.
Every year, over two million bone grafts are performed worldwide, due to diseases, sarcomas or trauma injuries [3] . In the USA, musculoskeletal injuries reach 32 million per year, of which, 45% are represented by tendon, ligament and joint capsular i njuries [4] . Autografts are considered as the gold standard procedure for treating small MSK defects due to their compatibility with patients. However, obtaining these grafts causes defects in secondary sites and can delay patient recovery time. Furthermore, autografts contribute additional trauma injury and are limited by size. For bigger defects, allogenic or biomaterial grafts are used. However, the use of allogenic grafts has several disadvantages including: immune rejection, the necessity for multiple surgical procedures to remove donor material, cost and limited tissue regeneration and revascularization potential [5] . Synthetic grafts can also inhibit vascularization and de novo tissue formation [6] . Tissue engineering advances can provide solutions to these problems. Nevertheless, traditional tissue engineering approaches are slow and cannot be used for large scale production of biological matter with the required complexity.
Bioprinting promises fast, on demand, and automated manufacturing of high resolution constructs. The process involves the use of 3D printing technologies to deposit cells or biological factors into predefined shapes and sizes [7] . Bioprinting permits s tringent However, laser-assisted technologies are also in development [7] . Details on the various 3D bioprinting techniques are reported elsewhere [8] .
To date, several research groups have bioprinted materials and cells for musculoskeletal applications. The two most common approaches used for 3D bioprinting include the printing of cell-free and cell-laden materials. Tables 1 & 2 outline how bone, cartilage, muscle, tendon and ligament tissues have been fabricated using these approaches. Figure 2 s ummarizes the benefits of each approach.
The current literature suggests that synthetic materials are more widespread for cell-free printing, while natural polymers have been commonly combined with cells, prior to extrusion. To evaluate the most popular approaches and materials used for bioprinting of musculoskeletal tissues, we reviewed the l iterature p ublished in this area during the last 15 years. Figure 3 summarizes the various materials used for 3D printing using cell-free and cell-laden approaches in MSK tissue engineering. The data suggest that around 84% of the materials used for cell-free printing are synthetic. This is primarily because these materials provide the strong mechanical properties required for musculoskeletal applications. The remaining 16% of articles show feasibility of this cell-free approach using natural materials, such as collagen and alginate, and this can be due to their higher biocompatibility compared with synthetic materials.
One good example of cell-free printing for bone repair focused on composite scaffold printing, where polycaprolactone-hydroxyapatite-carbon nanotubes were printed with pores in the range of 450-700 μm (Figure 4 ) [15] . This work highlights that cell-free biological materials can be classed as bioinks. Results show that a 4 MPa compressive strength was obtained and this is analogous to trabecular bone. The composite scaffolds also exhibited enhanced cell adhesion and improved hydroxyapatite bioactivity, when seeded with MG63 osteoblast-like cells. Nevertheless, the materials were distinct from native bone due to the presence of PCL and carbon nanotubes, and the cells were seeded in a traditional engineering approach. This led to uneven cell seeding/distribution.
In the literature, naturally derived biomaterials, such as alginate [14, 20] , collagen [14] , gelatin and fibrin [25] , have successfully promoted cell adhesion, Review Popov, Malferrari & Kalaskar proliferation and osteochondral differentiation with both cell-free and cell-laden printing approaches. However, natural materials were the most common materials used for cell-laden printing (70% of total reported in literature, Figure 3B ) for musculoskeletal applications. This is predominantly because of their capacity to form gels that can support cell e ncapsulation and survival during the 3D printing process.
Due to their poor mechanical properties, some of these natural biomaterials have been co-printed with other synthetic polymers for musculoskeletal applications. This can be realized by using multi-tool printing, which requires special modifications to printers such as incorporation of additional print heads or extruders. Daly et al. used multi-tool printing to produce a mechanically reinforced cartilaginous template mimicking the geometry of a vertebral disk [26] . This is an exciting study 197 www.futuremedicine.com future science group 3D bioprinting for musculoskeletal applications Review [26] 199 www.futuremedicine.com future science group 3D bioprinting for musculoskeletal applications Review Figure 5 . When implanted into a mouse model, the resultant bioprinted construct supported the development of vascularized bone containing trabecular-like endochondral bone with a s upporting marrow structure. Figure 6 . Production of engineered vascularized bone via 3D printing. Schematic illustration of the biomimetic architectural design and hierarchical fabrication process for printing of biphasic vascularized bone constructs using a FDM/SLA platform. FDM: Fused deposition modelling; SLA: Stereolithography. Reproduced with permission from [34] .
Native bone structure In another example using multi-tool printing, the vascularized bone was engineered when polylactic acid (PLA) was deposited with fused deposition modelling (FDM) printing technology, while gelatine methacryloyl (GelMA) containing BMP and VEGF was coprinted using stereolithography (SLA) [34] . This study demonstrated that the dual 3D printed constructs provided a hierarchically biomimetic bone-like structure, with multiphasic characteristics and potential for vascularized bone regeneration, as shown in Figure 6 . This is a noteworthy approach to produce complex tissue structures in the lab. However, it is important to stringently assess the functionality of this vascularized bone and make quantitative comparisons with native tissues.
In addition to this work, interesting results have been obtained using synthetic materials. Polyethylene glycol dimethyl acrylate was successfully inkjet printed with human chondrocytes for the repair of small osteochondral defects [24] . In another study, bone and cartilage tissues were fabricated through inkjet printing of human mesenchymal stem cells and simultaneous deposition and photo-crosslinking of polyethylene glycol dimethyl acrylate [35] . Others have achieved minimal print-head clogging by printing acrylate peptides and polyethylene glycol hydrogels with human mesenchymal stem cells to promote robust bone and cartilage formation [36] . Porous bioactive glass/alginate composite scaffolds have also been fabricated for bone tissue engineering using 3D printing [13] .
As a prospective treatment for cartilage lesions, recent study reported use of 3D bioprinting approach to form cartilage mimetics using a nanofibrillated cellulose and alginate-based composite bioink seeded with human-derived induced pluripotent stem cells and human chondrocytes [30] . The bioprinted constructs could maintain pluripotency initially, and after 5 weeks, hyaline-like cartilaginous tissue with collagen type II expression, lacking tumorigenic OCT4 expression was observed. Furthermore, a significant increase in cell number within the cartilaginous tissue was detected. This study combines 3D printing and stem cell technology to generate viable tissues for clinical applications.
While the majority of studies focus on bone and cartilage regeneration, recent work has shown progress in the bioprinting of other musculoskeletal tissues such as muscles and tendons. An integrated tissue-organ printer was used for the fabrication of skeletal muscle structures. The approach was based on the printing of well-defined PCL patterns for directional alignment of the muscle cells, as shown in Figure 7 . At the same time, cells were deposited using a mixture of hydrogels (gelatin, hyaluronic acid and fibrinogen), which were loaded with mouse myoblasts cells. Results showed good cell 203 www.futuremedicine.com 3D bioprinting for musculoskeletal applications Review viability, and alignment along the PCL pillars/patterns and muscle-like structures were observed after 7 days. When the constructs were implanted in vivo, they integrated with the common peroneal nerve after 2 weeks and the muscle was seen to respond to electrical stimuli [31] . Even though bioprinting examples in this area are limited, this study provides good evidence that 3D printing can be used for the development of various fibrous tissues (muscle, tendon and ligament) where cellular alignment is a key r equirement [37] . While various materials have been used as bioinks for printing cell-free and cell-laden constructs, cells alone in the form of tissue spheroids have also been i nvestigated for 3D bioprinting. Printed cells have a fluid nature and over time, they fuse together to form more complex cell aggregates that can potentially lead to tissue formation [38] . In the literature, tissue spheroids have already been successfully used for cartilage tissue engineering [39] [40] [41] . However, successful production of constructs using tissue spheroids is still in its infancy and focus needs to be applied on utilizing 3D printing technologies to help with scale-up, r eproducibility and formation of more complex structures [42, 43] .
Breakdown of the materials used as bioinks for bone and cartilage bioprinting in the last 15 years show some interesting trends. The majority of all the cell-free (Figure 3 ). In contrast, alginate was the most popular material for cell-laden bioinks (25%) and this was followed by PCL (21%) and collagen (9%). Alginate was applied due to its good printability, while PCL is a biocompatible mechanical strength enhancer of the cell-laden hydrogels. Notably, there is greater variety in the materials used for cellladen printing than cell-free printing. 3D printing has been successfully applied in a variety of ways to address the growing demand for more robust musculoskeletal therapies. Nevertheless, the use of the technology for medical purposes is still in its infancy. There is need for further research and development in both 3D printing technology and bio-ink formulations for successful translation of this t echnology in future.
Musculoskeletal bioinks & their characteristics
Bioinks are an integral part of the bioprinting process. Most frequently, they are defined as hydrogel materials used for the encapsulation of cells in 3D bioprinting [44] . However, this definition is very limited and there are a number of examples where b iological m aterials wi thout cells are also termed as bioinks [45] . Opinion on the exact definition of bioink remains divided. From the literature, it is clear that cell-only [46] , cells with supporting materials (both synthetic and natural hydrogels) [26] and biomolecules without cells (BMP2) [47] are also referred to as bioinks.
In the musculoskeletal context, the scenario is even more complex. As seen from the literature review in the previous section, musculoskeletal tissues have been bioprinted using three approaches: cell-free, cell-laden and combination of both approaches (i.e., multimode printing of synthetic polymers, along with encapsulated cells). The definition of bioinks becomes even hazier as the commonly used definition of encapsulated cells within material becomes very limited in its scope and application. We anticipate that as bioprinting research advances through the development of both hardware (3D printers) and novel materials that support this process, the need for an accurate and more inclusive definition will become apparent. Here we will focus on the various bioink used for musculoskeletal applications as reported in literature and define the requirements for the fabrication of functional MSK tissues. 
kPa). Glutaraldehyde crosslinking is cytotoxic
Bone and cartilage [63] Collagen Protein composed of glycine, praline and arginine to form tropocollagen fibers of diameters ranging from 50 to 200 nm. A: good swelling properties and biocompatibility. D: weak mechanical strength (mean peak stress: 0.76 MPa), poor printability and expensive Bone and cartilage [64] Fibrin Fibrin is a nonglobular protein present in the blood produced during blood clotting. Can be enzymatically crosslinked. A: good biocompatibility, swelling and gelation properties. Good printability. D: weak mechanical properties and expensive Bone [65] Gelatin Protein obtained from hydrolyzed collagen, which can be crosslinked using temperature and enzymes. A: low cost, biocompatible, biodegradable with high-cell adhesion. D: poor printability. Often found coupled to MA to form GelMA (crosslinked with UV light and harmful to cells), which has significantly increased mechanical properties and improved printability compared with gelatin Bone and cartilage [66, 67] HYA Polysaccharide and major component of ECM. (Photo) chemical crosslinking. A: good biocompatibility, good swelling ratio (0-45) fast degradation rates (100-0% residual mass in 8 days). D: weak mechanical properties (storage modulus 400-1000 Pa, loss modulus 3-30 Pa) and limited printability due to shear-thinning Bone [68] dECM Tissue decellularized ECM can be obtained using chemical, physical and biological treatments. A: representative of natural ECM environment, tissue-specific, guides for stem cell differentiation and good biocompatibility. D: nonhomogeneous cell seeding and immune reactions if cellular components remain. Decellularization treatments can damage natural ECM. Poor mechanical properties: max storage modulus of 300 and 0-20 Pa loss modulus Bone Skeletal muscle [69] [32]
Synthetic hydrogels PEG Synthetic polymer. Commonly crosslinked via chain-growth and step-growth polymerization, but can also be crosslinked using radiation and other chemical/physical methods. A: US FDA approved and does not trigger immunological responses. The material is soluble in water and organic solvents and has low protein adhesion properties. Good diffusion of nutrients and oxygen, and cell migration. When coupled to MA, it shows high swelling properties (swelling ratio from 37.88 to 100.93%) and good biocompatibility. Compressive modulus of 30-65 kPa and 1.63-6.99 cP viscosity. Good printability. D: often lack bioactive molecules Bone [36] Selfassembling peptides
Self-assembling peptide-based gels. A: versatile properties that can be easily tailored by adjusting chemicals and physical parameters. Good extracellular matrix mimicry, while biocompatible and biodegradable. Bioactive molecules can be incorporated. D: peptide gels are degraded by cellular proteolytic enzymes to cause shrinkage (20% of hydrogel volume in 12 days). Consequently, the mechanical properties become weaker (decrease from 50 to 10 Pa in 12 days) Bone [70] A D future science group
Review Popov, Malferrari & Kalaskar fabrication requirements for musculoskeletal bioinks. Most of these requirements are similar to soft tissue bioprinting; however, they become specific for musculoskeletal applications when additional mechanical stiffness and rigidity is required to fabricate structurally competent tissues. In the body, cells are found in highly organized environments, which are rich in water, nutrients and growth factors [48] . The review paper by Murphy provides an excellent overview Due to their significant water content, hydrogels have been identified as a primary material for bioprinting. Additionally, their hydrophilic nature allows hydrogels to retain large volumes of water without preventing a variety of crosslinking methods to be applied during fabrication of 3D networks [49] . In addition to this, hydrogels can be formulated to respond to various external stimuli such as temperature, electric or magnetic fields, light, pressure and sound vibrations before, during or after printing process [50] . Chemical factors including pH, solvent composition, ionic strength and molecular species also affect hydrogel properties. Therefore, a good understanding of these parameters on printability, stability in both in vitro and in vivo environments becomes essential.
Materials for bioprinting must be biocompatible and mimic natural cellular or tissue environment [51, 52] . Specifically, materials used for cell encapsulation must mimic the natural environment of cells and it has been demonstrated that hydrogels based on extracellular matrix components permit this [53, 54] .
In terms of fabrication, printing materials should exhibit good printability and sufficient mechanical properties for cellular support and maintenance of the 3D structures [51] . For example, since highly viscous hydrogels are prone to clogging phenomena in the nozzles of extrusion-based printers, shear-thinning of some hydrogels, such as hyaluronic acid and peptide gels, can be advantageous [55, 56] . However, it is important to adapt these hydrogels so they are able to 'selfheal' and maintain their printed structure once deposited [57] . Gelation time, along with the capacity to respond to physiological shear, tensile and compressive stresses, are other key parameters in bioprinting, which determine whether a printed construct can maintain its structure in a physiological environment [58, 59] .
Hydrogels for bioprinting of musculoskeletal tissues can be classified as natural or synthetic depending on their origin [60, 61] and the most common ones used in the literature are summarized in Table 3 .
Most natural hydrogels are based on components of the mammalian extracellular matrix (ECM), even though polymers from alternative sources, such as algae, are gaining interest [71] . Natural hydrogels show significant bioactivity compared with synthetic materials due to the intrinsic presence of biomolecules used for signaling, adhesion, biocompatibility and self-remodeling [2] . While bioactive components are important for cell growth and differentiation, the application of natural materials can lead to batch-tobatch variability, immunogenic reactions and disease transmission [72] . Interestingly, it has been observed that natural polymers, such as hyaluronic acid, laminin, fibronectin and collagen, are more susceptible to cell-driven biodegradation [73] .
It is important to note that as well as individual components of the ECM, decellularized ECM has similarly been successfully utilized as bioinks in the printing of tissue analogs [74, 75] . Tissue decellularized ECM can be obtained using chemical, physical and biological treatments and provides an excellent representation of the natural ECM environment [76] . At the same time, decellularized ECM can lead to nonhomogeneous cell seeding and immune reactions, if cellular components are not fully removed [76] . Furthermore, decellularization treatments can damage the natural ECM and show poor mechanical properties in the material.
Synthetic materials are advantageous in terms of reproducibility and ease of processing compared with natural polymers. These polymers can sometimes lead to immunogenic reactions after partial degradation, but this can be controlled and accelerated with the addition of matrix metalloproteinases, which show excellent biocompatibility [77, 78] . Furthermore, synthetic materials can be tailored to form complexes with ECM proteins by covalent crosslinking.
These covalently bound molecules can be adhesion proteins or growth factors that enhance cell response within the hydrogels [58] .
Challenges in bioprinting of musculoskeletal tissues
In addition to the hardware used for bioprinting, material availability and their selection are significant challenges and limitations for the success of bioprinting in musculoskeletal tissue fabrication. Materials/bioinks composed of naturally derived materials are limited in their application due to batch-to-batch variability and often lack the mechanical strength required to mimic the in vivo environment of native musculoskeletal tissues [59] . In the literature, this issue is often resolved by combining the natural inks with stronger biocompatible materials, such as PCL, PLA and PLGA [9, 17] , as described previously.
Furthermore, bioinks are presently limited by their printability and resolution. Materials are often required to be viscous in order to maintain the morphology of printed structures and improve mechanical strength, 207 www.futuremedicine.com future science group 3D bioprinting for musculoskeletal applications Review but this can lead to blockages and unreliable material deposition. Importantly, this has adverse effects on the print quality and resolution, which can be detrimental to achieving the highly hierarchical structures in the tissues of the MSK.
Tuneable, synthetic bioinks can provide a wide range of desirable properties, including controlled mechanics, degradation and printability. However, the techniques required to synthesize and crosslink these materials can cause cytotoxicity and prevent the ability to incorporate cells during the print process. For example, the monomers and photo initiators in some printable materials are toxic, but following UV crosslinking, the polymers formed are biocompatible and can support cell survival [79, 80] .
Further, printing of mechanically stable gelatin in the form of GelMA traditionally requires UV light during the print process and can damage cells. Recently, this challenge has been overcome by developing GelMA that can be crosslinked using visible light [81] . Crosslinking of natural bioinks can similarly be associated with cytotoxicity, but this can often be alleviated by using low crosslinker concentrations or replacing with nontoxic analogs. For example, calcium chloride is used for crosslinking alginate, whereas glutaraldehyde is used for crosslinking collagen, gelatin or chitosan. Calcium chloride is not toxic at low concentrations, while glutaraldehyde can be replaced with alternatives like genipin, during the crosslinking of collagen, gelatin and chitosan [82] [83] [84] .
Hydrogels are the most utilized materials in bioprinting, due to their high water content and parallels to native ECM. However, these biomaterials show poor mechanical properties, so compromises must be made when considering characteristics such as composition, printability and mechanical strength. In the bioprinting of musculoskeletal tissues this has been overcome to an extent by incorporating multiple printing technologies at the same time. This approach permits deposition of materials with good mechanical properties and cell-laden bioinks, within a single e ngineered construct [21, 26] .
Furthermore, the fundamental layer-by-layer nature of most printing techniques leads to difficulties in producing complex and hollow structures. This can be resolved by incorporating sacrificial materials for structural support during the fabrication process but this also increases the technological complexity, cost and time of the printing. Once the resolution, reproducibility, speed and customization of current printing technologies have been defined and optimized, bioprinting can provide cost-effective and high-throughput systems for drug screening and tissue replacement. Importantly, robust methods for construct maturation and long-term maintenance, as well as quality control measures for bioprinted tissues, need to be considered in parallel with the technological advances of printers. Regulatory concerns, such as the ethics of stem cells and the use of Class II medical devices are also key factors to contemplate, for the success of bioprinting approach. Furthermore, at present there are no specific 3D bioprinting regulations defined by the Medicines and Healthcare Products Regulatory Agency in the UK or US FDA in the USA.
Future perspective
Printing of natural ECM-based materials embedded with cells provides significant advantages for tissue engineering, including biocompatibility, robust control of cell distribution and density within the scaffold. Nevertheless, traditionally materials have been produced and seeded with cells afterward, and this can also be applied to printed constructs. In fact, this approach permits scaffolds with enhanced mechanical properties and resolution that natural materials often lack for musculoskeletal applications. Furthermore, coprinting of cell-laden and cell-free materials has been revealed to be beneficial for musculoskeletal tissue engineering applications [12, 21, 26] . All these approaches (cell-laden, cell-free and a combination of both) aim to obtain a complex, living tissue able to develop and mature, using the same fundamental technology.
The bioprinting literature suggests that the definition of bioinks remains ambiguous. This is because various components such as cells, biomolecules, synthetic materials either alone or in combination, are all defined as bioinks by different groups. Consensus on bio-ink definition is required. With the development of new bioinks in the future, nanobiofabrication of organs will become a reality and this will help to alleviate the increasing organ shortages worldwide. More specifically, technological advances in material science and engineering will permit versatility, nanoscale resolution and controllable distributing of cells and biomaterials, for a range of biomedical applications, i ncluding musculoskeletal repair.
The literature shows that bioprinting of muscles, tendons and ligaments is still a challenge; however, promising progress has been made in bioprinting of bone and cartilage. Stiff materials have been combined with natural cell-laden hydrogels to form composite constructs that are mechanically stable with the ability to mimic the native ECM environment of osteochondral tissues. Further, it has been demonstrated that these scaffolds can be combined with stem cells to permit osteochondral development in vivo [26] . Progress has even been made in the bioprinting of vascularized bone [34] . Biosensors for bone formation [85] , and pro- Bioprinting is an automated additive manufacturing process that permits the fabrication of 3D structures by selectively depositing biological materials layer-by-layer.
Bioprinting & its role in musculoskeletal tissue fabrication
Bioprinting in the literature shows promise for musculoskeletal regeneration. Greater understanding of the native environment in tissues and organs is required to maintain cell viability. Printer hardware needs to be developed to combine cell health with desired biomaterials characteristics.
Musculoskeletal bioinks & their characteristics
Bioinks can be printable biological materials that must be compatible with the biological, chemical and physical requirements of native tissues. To be suitable for musculoskeletal applications, a bioink must have suitable mechanical strength for cellular support and maintenance in 3D structures. A range of natural and synthetic materials have been used for musculoskeletal applications. Natural materials provide the biological properties for tissue development but lack the mechanical strength of bone and cartilage. Synthetic materials provide a solution to this challenge but are less bioactive. The most promising examples in the literature, combine cell-free and cell-laden printing.
Challenges in bioprinting of musculoskeletal tissues
Bioinks cannot currently mimic the environments that cells experience in vivo. Printing living cells is challenging because there are multiple variables that need to be controlled and optimized when cells are combined with biomaterials. Hard tissues require mechanical strength that natural hydrogels often lack and synthetic materials can be detrimental to cell viability.
Future perspective
Bioinks must meet the following requirements: biocompatibility, biodegradability, good printability and sufficient mechanical strength for cellular support and maintenance of the 3D structures. The use of bioinks in bioprinting remains a developing and expanding multidisciplinary technology with substantial potential for the future successes of tissue engineering and regenerative medicine.
tein and DNA arrays of stem cells [86, 87] have already been bioprinted, while next generation printable materials for controlling osteochondral cellular microenvironments are also in development. Nevertheless, these examples are all proof of concept studies and significant validation and development of next generation bioinks and their printing process is required in the future.
Fundamentally, the success of bioprinting in tissue engineering is heavily reliant on improvements in bioink properties, printing technologies, vascularization of tissues and controlled scaffold and cell maturation. Crucially for bone and cartilage applications, it is important to improve the mechanical properties of bioinks and to maximize the resolution of the printed constructs. Innovative bioinks with benefits for musculoskeletal applications that are currently being developed include, dynamic switchable hydrogels with local variations in the density and size of collagen fibers throughout 3D tissues [88, 89] , and oxygen releasing b iomaterials [90, 91] .
Conclusion
Bioprinting promises to be an important tool to fabricate complex tissue and organs. However, there are significant challenges to be resolved in terms of technological advances. Research to date has laid strong foundations and promise for the feasibility in manufacturing artificial organs, including musculoskeletal tissues. Bioprinting and the use of bioinks remain developing and expanding multidisciplinary fields of research with substantial potential for the future successes of tissue engineering and regenerative medicine.
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